- Home
- INDP vs SGLY Comparison
INDP vs SGLY Comparison
Compare INDP & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- SGLY
- Stock Information
- Founded
- INDP 2000
- SGLY 2001
- Country
- INDP United States
- SGLY United States
- Employees
- INDP N/A
- SGLY N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- INDP Health Care
- SGLY
- Exchange
- INDP Nasdaq
- SGLY Nasdaq
- Market Cap
- INDP 4.0M
- SGLY 3.4M
- IPO Year
- INDP N/A
- SGLY 2008
- Fundamental
- Price
- INDP $2.60
- SGLY $0.61
- Analyst Decision
- INDP Strong Buy
- SGLY
- Analyst Count
- INDP 1
- SGLY 0
- Target Price
- INDP $140.00
- SGLY N/A
- AVG Volume (30 Days)
- INDP 67.5K
- SGLY 117.3K
- Earning Date
- INDP 11-07-2025
- SGLY 11-14-2025
- Dividend Yield
- INDP N/A
- SGLY N/A
- EPS Growth
- INDP N/A
- SGLY N/A
- EPS
- INDP N/A
- SGLY N/A
- Revenue
- INDP N/A
- SGLY $1,813,193.00
- Revenue This Year
- INDP N/A
- SGLY N/A
- Revenue Next Year
- INDP N/A
- SGLY N/A
- P/E Ratio
- INDP N/A
- SGLY N/A
- Revenue Growth
- INDP N/A
- SGLY N/A
- 52 Week Low
- INDP $2.22
- SGLY $0.54
- 52 Week High
- INDP $47.60
- SGLY $5.49
- Technical
- Relative Strength Index (RSI)
- INDP 41.62
- SGLY 35.43
- Support Level
- INDP $2.45
- SGLY $0.58
- Resistance Level
- INDP $3.76
- SGLY $0.65
- Average True Range (ATR)
- INDP 0.28
- SGLY 0.04
- MACD
- INDP -0.05
- SGLY 0.01
- Stochastic Oscillator
- INDP 30.63
- SGLY 16.47
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.